SCHEMBL19960193

SCHEMBL19960193

O=P(c1ccc2ccccc2c1)(c1ccc2ccccc2c1)c1cccc2nc3c4c5ccccc5ccc4c4cc5ccccc5cc4n3c12

nearest known ligand 0.30

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.30
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
GAA P10253 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19960092 0.93 CAMKK1 (0.32)
SCHEMBL19960137 0.93 USP2 (0.33) USP2ALDH1A1LMNAGAATSHR
SCHEMBL19960130 0.86 KMT2A (0.36) USP2ALDH1A1LMNAGAATSHR
SCHEMBL20090139 0.84 FLT3 (0.32)
SCHEMBL19960185 0.84 AHR (0.35) LMNA
SCHEMBL19960131 0.84 BCL2 (0.35) USP2ALDH1A1LMNAGAATSHR
SCHEMBL19960243 0.83 NPSR1 (0.32)
SCHEMBL19959882 0.83 ALDH1A1 (0.33) USP2ALDH1A1LMNAGAATSHR
SCHEMBL19960053 0.83 KMT2A (0.35) ALDH1A1LMNAGAA
SCHEMBL20090136 0.82 FLT3 (0.32) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-06-30 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 USP2 2746/4885ALDH1A1 750/4885LMNA 3023/4885
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 USP2 2746/4885ALDH1A1 750/4885LMNA 3023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.